Has Vinod Dasa, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,916,005 in general payments to Vinod Dasa, MD across 1,345 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vinod Dasa, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vinod Dasa, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vinod Dasa, MD

Orthopaedic Surgery · Kenner, LANPI 1215139431

Payments from drug & device makers

$1,916,005in general payments, 2019–2025

Across 1,345 payments — averaging $1424.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pacira Pharmaceuticals Incorporated$944K
Bioventus LLC$605K
Vertex$149K
Smith+Nephew$76K
Stryker$32K
Sanara Medtech Inc.$27K
plus $83K from 43 others

$19,721in research payments, 2019–2025

Across 5 payments — averaging $3944.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Motive Health, Inc.$12K
Bioventus LLC$5K
Seikagaku Corporation$2K

What the payments were for

Consulting fees$803,60243%
Speaking & faculty fees$723,37538%
Travel & lodging$139,2897%
Food & beverage$30,0942%
Education$70%
Ownership interest$184,24710%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pacira Pharmaceuticals Incorporated	553	$943,504
Bioventus LLC	368	$605,302
Vertex	122	$149,128
Smith+Nephew	84	$76,474
Stryker	42	$31,923
Sanara Medtech Inc.	25	$27,056
Curonix LLC	25	$21,150
Myoscience Inc.	19	$20,206
Sanofi-aventis U.S. LLC	6	$10,221
Teleflex LLC	6	$7,443
Pacira Cryotech Incorporated	2	$5,099
Anika Therapeutics, Inc.	8	$4,595
Ferring Pharmaceuticals Inc.	4	$3,630
KCI USA, Inc.	3	$2,728
Acelrx Pharmaceuticals, Inc.	1	$2,000
Zimmer Biomet	12	$924
Ossio Inc	5	$751
Motive Health, Inc.	6	$670
Arbutus Medical, Inc	1	$550
Maxx Orthopedics, Inc.	3	$337
Medacta USA, Inc.	8	$228
Heron Therapeutics, Inc.	3	$180
Edwards Lifesciences	1	$156
Conformis, Inc.	2	$144
Think Surgical, Inc.	1	$140
Cartiheal (2009) LTD.	1	$139
Pacira Therapeutics, Inc.	6	$128
Baudax Bio Inc.	3	$122
Lilly USA, LLC	1	$122
Innocoll Pharmaceuticals Limited	1	$119
Davol Inc.	1	$116
Next Science LLC	1	$110
Stimwave Technologies Incorporated	2	$103
Restor3d, Inc.	1	$102
SPR Therapeutics, Inc	2	$76
Fidia Pharma USA Inc.	2	$60
Acera Surgical, Inc.	1	$38
Nalu Medical, Inc.	2	$34
Organogenesis Inc.	1	$33
Brainlab, Inc.	1	$21
Bsn Medical Inc	1	$20
Convatec Inc.	1	$18
Avanos Medical	1	$17
Heraeus Medical, LLC.	1	$16
Integra Lifesciences Corporation	1	$15
Saluda Medical Americas, Inc.	1	$15
Vericel Corporation	1	$14
UCB, Inc.	1	$14
Pfizer	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EXPAREL$501,988
Iovera$426,198
Durolane$411,126
Zilretta$156,621
IOVERA SYSTEM$146,917
JOURNAVX$89,832
Stimrouter Implantable Kit$70,153
Exogen Ultrasound Bone Healing System$28,294
CellerateRx$26,790
PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$20,711
SYNVISC$8,900
Arrow$7,383
NONE$6,375
Exogen$4,802
TACTOSET$4,200
EUFLEXXA$3,600
DSUVIA$2,000
Other$1,624
XCELL$1,125
Double Endobutton$898

How this compares

$1,916,005 in reported general payments places this provider in the 95th percentile of 286 orthopaedic surgery providers in Louisiana.

See all orthopaedic surgery providers in Louisiana →

Medicare billing

Part B allowed, 2024

$38,395

Medicare patients

Services billed

363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	62	$547
Gabapentin	31	$159
Cyclobenzaprine Hcl	35	$73
Tramadol Hcl	16	$47

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Kenner

Ian ElliottKenner$99K
Pierce NunleyShreveport$3.8M
Christopher HarrodBaton Rouge$3.1M
Jorge IsazaBaton Rouge$1.2M
Robert ZuraNew Orleans$792K
Kevin McCarthyBaton Rouge$714K
Fernando SanchezNew Orleans$655K
Neil MakiThibodaux$620K
Timmothy RandellAlexandria$498K
Robert EastonBaton Rouge$394K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →